U.S. Benign Prostatic Hyperplasia (BPH)
Procedures is
expected to grow at a CAGR of 4.2% during 2017 - 2023
Increase in the aging population in the U.S in the
next few years, is expected to create high demand for BPH treatments, since the
population aged 50 years and above is more prone to BPH, and therefore tend to
opt for various treatments that involve the use of procedures such as TURP,
TUIP and laser based treatments.
According to the National Institute of Health, it has
been estimated that around 14 million men in the U.S. had symptoms suggestive
of BPH, which can affect 50% of men aged between 51 and 60 years of age, and up
to 90% of men aged more than 80 years. With 50% of men getting affected with
BPH, there is a consequent increase in the BPH procedures.
Download Report Sample at: https://www.psmarketresearch.com/market-analysis/us-bph-procedures/report-sample
As per the findings of the research, the different
type of BPH treatment procedure include laser based procedures, surgical
procedures, UroLift and other energy based procedures. Laser based procedures
is expected to account for the largest share in the U.S. BPH procedures during
the forecast period, since these procedures are more effective, as compared to
the conventional procedures and are less likely to cause bleeding and other
complications. Urolift is projected to register the fastest growth during the
forecast period, mainly driven by the aging U.S. population, expanding
insurance coverage of the procedure by various insurers, low cost of the
procedure, and possibility of indication expansion of the UroLift procedure for
the treatment of patients with BPH who have an obstructive median lobe.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=us-bph-procedures
Key player in the U.S. BPH procedures are acquiring
other players to offer advanced products for BPH treatment procedures. For
instance, in September 2017, Teleflex Incorporated, announced that the company
has entered into definitive agreement with NeoTract, Inc. Under the terms of
the agreement, Teleflex Incorporated agreed to acquire NeoTract, Inc. for a
consideration of up to $1.1 billion. With this agreement, Teleflex Incorporated
would be able to leverage the potential long-term benefits from NeoTracts, Inc.
second generation UroLift system, which is expected to launch in the mid of
2018.
Some of the other key players providing products for
BPH procedures in the U.S. include NxThera, Inc., Boston Scientific
Corporation, Urologix, LLC., Convergent Laser Technologies.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886
(USA/Canada)
Email: enquiry@psmarketresearch.com
